View in EDS PDF Full Text

Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features.

Saved in:
Bibliographic Details
Title: Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features.
Authors: Gangaev A; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands., Ketelaars SLC; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands., Isaeva OI; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands., Patiwael S; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands., Dopler A; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands., Hoefakker K; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands., De Biasi S; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy., Gibellini L; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy., Mussini C; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy., Guaraldi G; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy., Girardis M; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy., Ormeno CMPT; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, South Holland, The Netherlands., Hekking PJM; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, South Holland, The Netherlands., Lardy NM; Department of Immunogenetics, Sanquin Diagnostics B.V., Amsterdam, North Holland, The Netherlands., Toebes M; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands., Balderas R; Department of Biological Sciences, BD Biosciences, San Jose, CA, USA., Schumacher TN; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands., Ovaa H; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, South Holland, The Netherlands., Cossarizza A; University of Modena and Reggio Emilia School of Medicine, Modena, Emilia Romagna, Italy., Kvistborg P; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, North Holland, The Netherlands. p.kvistborg@nki.nl.
Source: Nature communications [Nat Commun] 2021 May 10; Vol. 12 (1), pp. 2593. Date of Electronic Publication: 2021 May 10.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2041-1723
DOI:10.1038/s41467-021-22811-y